Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lactobacillus Rhamnosus Lcr35® for Recurrent Aphthous Stomatitis
NCT02789605Phase 2Completed
- Sponsor
- Centre Hospitalier Universitaire de Nice
- Start
- Jan 2018
- Primary completion
- Nov 2019
- Modality
- Yeast Strains, Defined Consortia, Bacterial Strains
- Countries
- 1
01
Overview
A Phase 2 trial of lactobacillus rhamnosus Lcr35 in aphthous stomatitis (RAS), sponsored by Centre Hospitalier Universitaire de Nice. Started Jan 2018; status: completed.
02
Drugs
lactobacillus rhamnosus Lcr35
03
Conditions
aphthous stomatitis (RAS)
Beyond the preview
Go deeper on NCT02789605.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02789605.